Search

everythinglearnresearchcommunity

for

Search:↓

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

Progesterone's seizure-reducing effects are mainly due to allopregnanolone, not progesterone receptors.

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Blocking certain brain processes reduces mating behavior in female rats.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Blocking a specific receptor slows down hair loss in mice.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.